Skip to main content
Clinical Trials/JPRN-UMIN000036678
JPRN-UMIN000036678Completed未知

Effects of consumption of the test food on postprandial blood triglyceride and glucose in healthy Japanese subjects: a randomized, double-blind, placebo-controlled, crossover trial - Effects of consumption of the test food on postprandial blood triglyceride and glucose in healthy Japanese subjects

ORTHOMEDICO Inc.0 sites36 target enrollmentStarted: May 8, 2019Last updated:
Conditions

Trial Snapshot

Phase
未知
Status
Completed
Enrollment
36

Study Overview

Brief Summary

Kageyama M, Tomobe H, Kobashi R, Nakashima N, Akiyoshi K, Omori R, Yamada A, Takahashi Y, Takara T. The effects of consuming a tablet supplement containing Terminalia bellirica and banaba leaf extracts on postprandial blood triglycerides and glucose in healthy Japanese subjects-a randomized, double-blind, placebo-controlled, crossover trial. Pharmacol Ther. 2020; 48(11): 1999-2009

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
20years-old to ot applicable (—)
Sex
All

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1. Subjects who are undergoing medical treatment or have a medical history of malignant tumor, heart failure, and myocardial infarction 2. Subjects who have a pacemaker or an implantable cardioverter defibrillator (ICD) 3. Currently undergoing treatment for any of the following chronic diseases: cardiac arrhythmia, liver disease, kidney disease, cerebrovascular disorder, rheumatism, diabetes mellitus, dyslipidemia, hypertension, or any other chronic diseases 4. Subjects who use or take "Foods for Specified Health Uses", "Foods with Function Claims", or other functional food/beverage in daily. Particularly taking food/beverage effective in lowering blood sugar and anticoagulation in daily. 5. Subjects who are currently taking medications (including herbal medicines) and supplements. Particularly taking hypoglycemic agent and anticoagulants in daily. 6. Subjects who are allergic to medicines and/or the test food related products. Particularly allergic to soybeans, pork, beef, chicken, wheat, and milk. 7. Subjects who are pregnant, lactation, or planning to become pregnant 8. Subjects who have been enrolled in other clinical trials within the last three months before the agreement to participate in this trial or plan to enroll in anther clinical trial during trial period 9. Subjects who are planning to undergo a surgical operation within two weeks from the date of finish of the intervention period 10. Subjects who are ineligibility to participate in the study based on the evaluation of the principal physician

Investigators

Similar Trials